| Literature DB >> 31844432 |
Hedaiat Moradpoor1, Mohsen Safaei2, Farzad Rezaei3, Amin Golshah4, Ladan Jamshidy1, Reza Hatam5, Rawand S Abdullah6.
Abstract
AIM: With the increased bacterial resistance and the resulting problems in recent years, it seems necessary to find new biocompatible compounds to confront this problem. This research was conducted to optimise the synthesis of cobalt oxide nanoparticles with the highest antibacterial activity.Entities:
Keywords: Antibacterial activity; Biomedical application; Cobalt Oxide; Metal nanoparticles; Taguchi method
Year: 2019 PMID: 31844432 PMCID: PMC6901869 DOI: 10.3889/oamjms.2019.747
Source DB: PubMed Journal: Open Access Maced J Med Sci ISSN: 1857-9655
Taguchi design of experiments and antibacterial effect of manufactured cobalt oxide nanoparticles on gram-positive and gram-negative bacteria
| Experiment | Cobalt nitrate (M) | KOH (M) | Stirring time (min) | Bacterial survival (Log10 CFU/ml) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.2 | 0.4 | 0.6 | 1 | 2 | 3 | 30 | 60 | 90 | Gram-positive | Gram-negative | |
| 1 | 0.2 | 1 | 30 | 6.42 | 6.76 | ||||||
| 2 | 0.2 | 2 | 60 | 5.84 | 6.13 | ||||||
| 3 | 0.2 | 3 | 90 | 5.10 | 5.32 | ||||||
| 4 | 0.4 | 1 | 60 | 5.32 | 5.51 | ||||||
| 5 | 0.4 | 2 | 90 | 5.60 | 5.71 | ||||||
| 6 | 0.4 | 3 | 30 | 4.94 | 5.06 | ||||||
| 7 | 0.6 | 1 | 90 | 4.40 | 4.75 | ||||||
| 8 | 0.6 | 2 | 30 | 4.76 | 4.89 | ||||||
| 9 | 0.6 | 3 | 60 | 3.72 | 3.97 | ||||||
The main effects of factors of cobalt nitrate, KOH and stirring times at different levels on the bacterial survival
| Factors | Gram positive bacteria ( | Gram-negative bacteria ( | ||||
|---|---|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Level 1 | Level 2 | Level 3 | |
| Cobalt nitrate | 5.79 | 5.29 | 4.29 | 6.07 | 5.43 | 4.54 |
| KOH | 5.38 | 5.40 | 4.59 | 5.67 | 5.58 | 4.78 |
| Stirring time | 5.37 | 4.96 | 5.03 | 5.57 | 5.20 | 5.26 |
The interactions among studied factors on the survival rate of bacteria
| Interacting factor pairs | Column | Severity Index (%) | Optimum conditions | |
|---|---|---|---|---|
| Gram-positive bacteria ( | KOH × Stirring time | 2×3 | 40.37 | [3,2] |
| Cobalt nitrate × Stirring time | 1×3 | 17.77 | [3,2] | |
| Cobalt nitrate × KOH | 1×2 | 15.92 | [3,3] | |
| Gram-negative bacteria ( | KOH × Stirring time | 2×3 | 44.62 | [3,2] |
| Cobalt nitrate × Stirring time | 1×3 | 19.35 | [3,2] | |
| Cobalt nitrate × KOH | 1×2 | 14.87 | [3,3] |
The ANOVA test for studied factors on reducing the growth of bacteria
| Type of bacteria | Factors | DOF | Sum of Squares | Variance | F-Ratio (F) | Pure Sum | Percent (%) |
|---|---|---|---|---|---|---|---|
| Gram positive bacteria ( | Cobalt nitrate | 2 | 3.47 | 1.73 | 49.74 | 3.40 | 66.35 |
| KOH | 2 | 1.29 | 0.64 | 18.53 | 1.22 | 23.86 | |
| Stirring time | 2 | 0.29 | 0.14 | 4.19 | 0.22 | 4.34 | |
| Gram negative bacteria ( | Cobalt nitrate | 2 | 3.56 | 1.78 | 39.18 | 3.47 | 65.25 |
| KOH | 2 | 1.43 | 0.71 | 15.76 | 1.34 | 25.22 | |
| Stirring time | 2 | 0.23 | 0.12 | 2.57 | 0.14 | 2.69 |
DOF, degree of freedom.
Predicted the optimal conditions for producing cobalt oxide nanoparticles with the highest antibacterial activity
| Factors | Gram-positive bacteria ( | Gram-negative bacteria ( | ||
|---|---|---|---|---|
| Level | Contribution | Level | Contribution | |
| Cobalt nitrate | 3 | 0.83 | 3 | 0.81 |
| KOH | 3 | 0.54 | 3 | 0.56 |
| Stirring time | 2 | 0.16 | 2 | 0.14 |
| Total contribution from all factors | 1.53 | 1.51 | ||
| Current grand average of the performance | 5.12 | 5.34 | ||
| Bacterial survival at optimum condition | 3.59 | 3.83 | ||
The bactericidal activity of synthesised cobalt oxide nanoparticles in optimal conditions
| Type of essay | Type of bacteria | Bactericidal activity | |
|---|---|---|---|
| Cobalt Oxide | Gentamycin | ||
| Bacterial survival (Log10 CFU/ml) | Gram positive bacteria ( | 3.60 | 2.56 |
| Gram negative bacteria ( | 3.78 | 2.84 | |
| Zone of inhibition (mm) | Gram-positive bacteria ( | 15 | 17 |
| Gram negative bacteria ( | 14.66 | 15.66 | |
Figure 1FTIR spectra synthesised cobalt oxide nanoparticles
Figure 2XRD pattern of synthesised cobalt oxide nanoparticles
Figure 3SEM image of synthesised cobalt oxide nanoparticles